Simplex Trading’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.28M | Sell |
5,700
-2,400
| -30% | -$598K | ﹤0.01% | 2244 |
|
|
2025
Q4 | $1.95M | Sell |
8,100
-6,800
| -46% | -$1.74M | ﹤0.01% | 2007 |
|
|
2025
Q3 | $4.08M | Sell |
14,900
-1,000
| -6% | -$273K | ﹤0.01% | 1659 |
|
|
2025
Q2 | $4.1M | Sell |
15,900
-77,600
| -83% | -$18.5M | ﹤0.01% | 1513 |
|
|
2025
Q1 | $20.9M | Sell |
93,500
-3,600
| -4% | -$840K | 0.01% | 506 |
|
|
2024
Q4 | $22.2M | Buy |
97,100
+35,100
| +57% | +$8.45M | 0.01% | 580 |
|
|
2024
Q3 | $15.1M | Buy |
62,000
+500
| +0.8% | +$112K | 0.01% | 786 |
|
|
2024
Q2 | $11.8M | Sell |
61,500
-99,100
| -62% | -$20.1M | 0.01% | 914 |
|
|
2024
Q1 | $31.8M | Buy |
160,600
+103,500
| +181% | +$19M | 0.02% | 488 |
|
|
2023
Q4 | $9.82M | Buy |
57,100
+26,500
| +87% | +$4.07M | 0.01% | 1097 |
|
|
2023
Q3 | $4.52M | Buy |
30,600
+30,100
| +6,020% | +$5.44M | ﹤0.01% | 1427 |
|
|
2023
Q2 | $109K | Sell |
500
-3,900
| -89% | -$869K | ﹤0.01% | 4979 |
|
|
2023
Q1 | $963K | Sell |
4,400
-12,400
| -74% | -$2.69M | ﹤0.01% | 2623 |
|
|
2022
Q4 | $3.5M | Buy |
16,800
+15,300
| +1,020% | +$3.36M | ﹤0.01% | 1452 |
|
|
2022
Q3 | $327K | Buy |
1,500
+300
| +25% | +$68.3K | ﹤0.01% | 3977 |
|
|
2022
Q2 | $251K | Sell |
1,200
-24,500
| -95% | -$5.22M | ﹤0.01% | 4331 |
|
|
2022
Q1 | $6.23M | Sell |
25,700
-200
| -0.8% | -$48.4K | 0.01% | 1097 |
|
|
2021
Q4 | $6.75M | Buy |
25,900
+14,600
| +129% | +$3.79M | 0.01% | 1019 |
|
|
2021
Q3 | $2.8M | Sell |
11,300
-2,500
| -18% | -$684K | ﹤0.01% | 1747 |
|
|
2021
Q2 | $3.4M | Buy |
13,800
+13,795
| +275,900% | +$2.9M | ﹤0.01% | 1546 |
|
|
2021
Q1 | $97K | Sell |
5
-30
| -86% | -$6.02K | ﹤0.01% | 5792 |
|
|
2020
Q4 | $743K | Sell |
35
-130
| -79% | -$25.9K | ﹤0.01% | 2933 |
|
|
2020
Q3 | $2.83M | Buy |
165
+131
| +385% | +$24.2K | ﹤0.01% | 1254 |
|
|
2020
Q2 | $652K | Sell |
34
-3
| -8% | -$491 | ﹤0.01% | 2601 |
|
|
2020
Q1 | $544K | Buy |
37
+30
| +429% | +$4.78K | ﹤0.01% | 2499 |
|
|
2019
Q4 | $108K | Sell |
7
-3
| -30% | -$432 | ﹤0.01% | 4446 |
|
|
2019
Q3 | $135K | Sell |
10
-13
| -57% | -$1.7K | ﹤0.01% | 3979 |
|
|
2019
Q2 | $280K | Sell |
23
-133
| -85% | -$14.7K | ﹤0.01% | 3137 |
|
|
2019
Q1 | $1.62M | Sell |
156
-10
| -6% | -$1.03K | ﹤0.01% | 1561 |
|
|
2018
Q4 | $1.89M | Buy |
166
+130
| +361% | +$13.9K | 0.01% | 1131 |
|
|
2018
Q3 | $415K | Sell |
36
-79
| -69% | -$8.65K | ﹤0.01% | 2828 |
|
|
2018
Q2 | $1.19M | Buy |
115
+106
| +1,178% | +$10.7K | ﹤0.01% | 1632 |
|
|
2018
Q1 | $1K | Buy |
+9
| New | +$850 | ﹤0.01% | 5754 |
|
|
2017
Q2 | – | Sell |
-389
| Closed | -$20K | – | 6685 |
|
|
2017
Q1 | $20K | Buy |
389
+223
| +134% | +$15.4K | ﹤0.01% | 3267 |
|
|
2016
Q4 | $13K | Buy |
166
+75
| +82% | +$4.59K | ﹤0.01% | 3482 |
|
|
2016
Q3 | $21K | Buy |
91
+48
| +112% | +$3.19K | ﹤0.01% | 2919 |
|
|
2016
Q2 | $6K | Buy |
+43
| New | +$2.54K | ﹤0.01% | 4109 |
|
|
2016
Q1 | – | Sell |
-6
| Closed | -$5K | – | 6131 |
|
|
2015
Q4 | $5K | Sell |
6
-15
| -71% | -$846 | ﹤0.01% | 3896 |
|
|
2015
Q3 | $23K | Sell |
21
-208
| -91% | -$11.2K | ﹤0.01% | 2654 |
|
|
2015
Q2 | $198K | Buy |
229
+215
| +1,536% | +$13.6K | 0.02% | 801 |
|
|
2015
Q1 | $1K | Sell |
14
-15
| -52% | -$974 | ﹤0.01% | 4580 |
|
|
2014
Q4 | $1K | Buy |
+29
| New | +$1.51K | ﹤0.01% | 4238 |
|
Other funds holding RMD
VCM
VPM
DAM
Simplex Trading's RMD Position: Q2 2024 in Review
Simplex Trading sold out of ResMed (RMD) in Q2 2024, closing a stake of 7,430 shares — an estimated $1.51M sold.
Simplex Trading first reported a position in RMD in Q4 2014 and held it in 15 quarters. The position peaked at $2.03M in Q4 2021. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.
- Simplex Trading reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
- Simplex Trading sold 7,430 ResMed shares in Q2 2024, an estimated $1.51M.
- Simplex Trading first reported a position in ResMed in Q4 2014 and held it in 15 quarters.
- Simplex Trading's ResMed position peaked at $2.03M in Q4 2021.
- 771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.
Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.